Insider Trades of ORBIMED ADVISORS LLC Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date Type ▼ Tran OwnerType Shares Traded Last Price Shares Held
SUPERNUS PHARMACEUTICALS INC Beneficial Owner (10%) 02/12/2013 Form 4 Sell indirect 152,183 7.5218 858,100
SUPERNUS PHARMACEUTICALS INC Beneficial Owner (10%) 02/13/2013 Form 4 Sell indirect 150,000 7.5757 3,000,000
ACCELERON PHARMA INC Other 09/24/2013 Form 4 Acquisition (Non Open Market) indirect 2,109,642 0 2,117,648
INTERCEPT PHARMACEUTICALS INC Director 10/15/2013 Form 4 Sell indirect 376,585 62.5 1,775,347
INTERCEPT PHARMACEUTICALS INC Director 10/21/2013 Form 4 Sell indirect 40,088 62.5 1,735,259
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 10/29/2013 Form 4 Buy indirect 125,000 17.5 1,274,332
RESPONSE BIOMEDICAL CORP Beneficial Owner (10%) 11/07/2013 Form 4 Buy indirect 816,325 2.45 4,895,601
RELYPSA INC Beneficial Owner (10%) 11/20/2013 Form 4 Acquisition (Non Open Market) indirect 7,511,930 0 7,511,930
RELYPSA INC Beneficial Owner (10%) 11/20/2013 Form 4 Disposition (Non Open Market) indirect 27,282 11 8,907,342
RELYPSA INC Beneficial Owner (10%) 11/20/2013 Form 4 Buy indirect 712,192 11 9,941,551
INTERCEPT PHARMACEUTICALS INC Director 04/09/2014 Form 4 Sell indirect 81,305 320 1,654,603
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 06/27/2014 Form 4 Sell indirect 88,332 21.79 1,186,000
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 06/30/2014 Form 4 Sell indirect 14,000 20.33 1,172,000
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 07/01/2014 Form 4 Sell indirect 5,000 20.04 1,167,000
ROKA BIOSCIENCE, INC. Beneficial Owner (10%) 07/22/2014 Form 4 Acquisition (Non Open Market) indirect 2,832,364 0 2,810,334
ROKA BIOSCIENCE, INC. Beneficial Owner (10%) 07/22/2014 Form 4 Buy indirect 383,333 12 3,220,429
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Acquisition (Non Open Market) indirect 1,900,472 0 1,900,472
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Buy indirect 275,385 13 2,175,857
INTERCEPT PHARMACEUTICALS INC Director 08/14/2014 Form 4 Sell indirect 60,000 292.701 1,596,582
OTONOMY, INC. Beneficial Owner (10%) 08/18/2014 Form 4 Acquisition (Non Open Market) indirect 2,084,523 0 2,084,523

Latest News Headlines

View All
Create your free portfolio